Hormone Therapy and Sarcopenia: Testosterone, HGH, and Muscle Mass

Explore how testosterone, growth hormone, and other hormones influence age-related muscle loss. Learn the science, evidence, and clinical insights behind hormone therapy for sarcopenia.

DR T S DIDWAL MD

11/18/202511 min read

What if the muscle loss you’ve been blaming on “just getting older” is actually the result of powerful hormonal changes happening silently beneath the surface? Modern research now reveals that declining testosterone, growth hormone, and IGF-1 don’t just accompany aging—they actively accelerate sarcopenia. The good news? Understanding this hormone–muscle connection opens the door to targeted, evidence-based therapies that can help you maintain strength, mobility, and independence far into later life.

Clinical Pearls

1. Hormonal decline is a primary driver of sarcopenia

Age-related reductions in testosterone, estrogen, GH, and IGF-1 impair protein synthesis, mitochondrial function, and satellite cell activity—accelerating muscle loss.

2. Testosterone replacement improves lean mass most consistently

Meta-analyses show testosterone therapy reliably increases lean body mass in hypogonadal men, although functional gains depend heavily on concurrent resistance exercise.

3. SHBG levels may reveal “hidden” hormone deficiency

Elevated SHBG can significantly reduce free testosterone despite normal total levels, making free hormone assessment crucial when evaluating sarcopenia risk.

4. GH–IGF-1 axis impairment contributes to reduced anabolic signaling

Declines in GH and IGF-1 weaken mTOR activation and muscle repair pathways. GH therapy increases lean mass but functional improvements remain inconsistent.

5. Hormone therapy is most effective when combined with exercise

Resistance training amplifies androgen receptor sensitivity, boosts IGF-1 production, and synergizes with testosterone or GH to enhance strength and physical performance.

What Is Sarcopenia and Why Should You Care?

Sarcopenia is the progressive loss of skeletal muscle mass, strength, and function that occurs with aging. It's not just about aesthetics—losing muscle has serious consequences. Think increased fall risk, loss of independence, metabolic problems, and reduced quality of life.

The term comes from the Greek words "sarx" (flesh) and "penia" (loss), and it's now recognized as a distinct disease with its own diagnostic criteria. According to recent research, age-related sarcopenia begins subtly in your 30s and accelerates after 60, with muscle mass declining by 3-8% per decade after age 30 (Priego et al., 2021).

What makes sarcopenia particularly insidious is that it's multifactorial. Yes, physical inactivity plays a role, but so do nutrition, inflammation, mitochondrial dysfunction, and—critically—hormonal changes.

The Hormone-Muscle Connection: What the Science Shows

Sex Hormones: The Master Regulators of Muscle Health

Your muscles are incredibly hormone-sensitive tissues. Sex hormones, particularly testosterone in men and estrogen in women, play fundamental roles in maintaining muscle protein synthesis, preventing breakdown, and supporting muscle fiber health.

Hosoi et al. (2024) provide a comprehensive overview of how sex hormones influence sarcopenia and frailty. Their research reveals that these hormones don't just affect muscle quantity—they impact muscle quality, satellite cell function, mitochondrial health, and inflammatory responses. As we age, declining levels of these hormones create a perfect storm for muscle deterioration.

Key findings from Hosoi et al. (2024):

  • Sex hormone decline correlates strongly with sarcopenia onset

  • Hormones regulate muscle protein synthesis through multiple pathways

  • Androgen receptors in muscle tissue respond to testosterone

  • Estrogen plays protective roles in both men and women

  • Hormonal changes affect muscle regeneration capacity

The researchers emphasize that understanding these mechanisms is crucial for developing targeted hormone replacement therapies that can preserve muscle function in aging populations.

Testosterone: The Muscle-Building Powerhouse

Testosterone is perhaps the most studied hormone in relation to muscle mass maintenance. This anabolic hormone promotes protein synthesis, inhibits protein breakdown, and stimulates satellite cell activation—all critical processes for maintaining healthy muscle tissue.

Shin et al. (2018) conducted an extensive review examining the relationship between testosterone and sarcopenia in men. Their findings paint a clear picture: low testosterone levels (hypogonadism) are significantly associated with decreased muscle mass, reduced strength, and poor physical performance.

Key takeaways from Shin et al. (2018):

  • Testosterone levels decline by approximately 1-2% annually after age 30

  • Men with low testosterone show accelerated muscle loss

  • Testosterone influences both Type I and Type II muscle fibers

  • The hormone affects muscle through both direct and indirect mechanisms

  • Testosterone deficiency impacts muscle protein metabolism

The authors note that testosterone therapy has shown promise in reversing some aspects of sarcopenia, though they emphasize the need for careful patient selection and monitoring.

The Meta-Analysis Evidence: Does Testosterone Supplementation Really Work?

One of the most rigorous examinations of testosterone supplementation for sarcopenia comes from Parahiba et al. (2020), who conducted a systematic review and meta-analysis specifically focused on middle-aged and elderly men.

This study is particularly valuable because it synthesizes data from multiple randomized controlled trials, providing high-quality evidence about treatment effectiveness.

Key findings from Parahiba et al. (2020):

  • Testosterone supplementation significantly increased lean body mass

  • Improvements in muscle strength were observed but more variable

  • Effects were most pronounced in men with confirmed hypogonadism

  • Muscle quality improved alongside muscle quantity

  • Optimal dosing and duration remain under investigation

The meta-analysis revealed that while testosterone therapy consistently improved body composition, the effects on functional outcomes like walking speed and physical performance were less dramatic. This suggests that hormone therapy works best as part of a comprehensive approach that includes exercise and proper nutrition.

Beyond Testosterone: The Broader Hormonal Picture

Priego et al. (2021) expand our understanding by examining the role of multiple hormones in sarcopenia pathophysiology. Their comprehensive review in Vitamins and Hormones examines not just sex hormones, but also growth hormone (GH), insulin-like growth factor-1 (IGF-1), thyroid hormones, and glucocorticoids.

Key insights from Priego et al. (2021):

  • Growth hormone and IGF-1 decline with age, contributing to muscle loss

  • The GH-IGF-1 axis is crucial for muscle protein synthesis

  • Insulin resistance exacerbates sarcopenia

  • Cortisol (a glucocorticoid) promotes muscle catabolism

  • Thyroid hormones regulate metabolic rate and muscle function

This study emphasizes that sarcopenia results from a complex interplay of hormonal changes. The authors suggest that effective treatment may require addressing multiple hormonal pathways simultaneously rather than focusing on single hormone replacement.

Sex Hormone-Binding Globulin: An Underappreciated Player

Recent research by Qin et al. (2025) adds an important piece to the puzzle by examining the relationship between low muscle mass and sex hormone-binding globulin (SHBG). SHBG is a protein that binds to sex hormones in the blood, affecting how much "free" (active) hormone is available to tissues.

Key findings from Qin et al. (2025):

  • SHBG levels correlate inversely with muscle mass

  • High SHBG reduces free testosterone availability

  • The relationship differs between men and women

  • SHBG may serve as a biomarker for sarcopenia risk

  • Measuring SHBG alongside total testosterone provides better assessment

This research suggests that simply measuring total hormone levels isn't enough—we need to understand hormone bioavailability. Someone with "normal" total testosterone but high SHBG might effectively have low hormone activity at the muscle level.

The Androgen-Muscle Link: Mechanisms of Action

Basualto-Alarcón et al. (2014) provide crucial mechanistic insights into how androgens (male sex hormones like testosterone) directly influence muscle tissue. Their research explores the molecular pathways linking androgen receptors to muscle protein metabolism.

Key insights from Basualto-Alarcón et al. (2014):

  • Androgen receptors are abundant in skeletal muscle

  • Testosterone activates satellite cells for muscle repair

  • Androgens regulate myogenic transcription factors

  • The hormone influences mitochondrial function

  • Anabolic signaling pathways (mTOR, PI3K/Akt) are androgen-sensitive

The authors describe sarcopenia and androgen deficiency as interlinked pathologies that can create a vicious cycle: low hormones lead to muscle loss, which further disrupts hormonal balance and metabolic health. They argue that androgen therapy represents a logical treatment approach for reversing this cycle.

Practical Implications: What This Means for You

Who Should Consider Hormone Therapy for Sarcopenia?

Based on the research reviewed, hormone therapy isn't a one-size-fits-all solution. The best candidates typically include:

  • Men with documented low testosterone levels (below 300 ng/dL)

  • Individuals showing clinical signs of hypogonadism

  • People with progressive muscle loss despite adequate exercise and nutrition

  • Those with multiple risk factors for sarcopenia and frailty

It's crucial to work with a healthcare provider who can properly assess your hormonal status through blood tests measuring total testosterone, free testosterone, SHBG, and other relevant hormones.

What About Growth Hormone Therapy?

While testosterone has garnered most of the attention, growth hormone (GH) and IGF-1 also play important roles in muscle maintenance. However, GH therapy for sarcopenia remains more controversial due to potential side effects and higher costs.

The research suggests that GH supplementation can increase lean body mass, but whether this translates to meaningful functional improvements is less clear. Many experts recommend focusing on natural strategies to optimize the GH-IGF-1 axis first:

  • High-intensity resistance training

  • Adequate sleep (GH is released during deep sleep)

  • Proper nutrition with sufficient protein

  • Intermittent fasting (may boost GH naturally)

The Exercise Factor: Hormones Aren't Enough

Here's something critical that emerges from all these studies: hormone therapy works best when combined with resistance exercise. Multiple studies show that testosterone supplementation without exercise produces modest results, while the combination creates synergistic effects.

Resistance training stimulates muscle protein synthesis, improves hormone sensitivity in muscle tissue, and activates satellite cells—complementing hormonal effects. Think of hormones as providing the raw materials and signals, while exercise provides the stimulus that tells your body to actually build muscle.

For Women: A More Complex Picture

Most research on hormone therapy for sarcopenia focuses on men, but women face similar challenges with estrogen decline during menopause. The research by Hosoi et al. (2024) emphasizes that estrogen plays protective roles in muscle health, affecting protein synthesis, inflammation, and muscle regeneration.

Hormone replacement therapy (HRT) in postmenopausal women may help preserve muscle mass, though the evidence is still emerging. Women considering HRT should discuss both the potential benefits for muscle health and other health considerations with their healthcare providers.

Safety Considerations and Potential Risks

While the research shows promising benefits of hormone therapy for muscle loss, it's essential to acknowledge potential risks:

Testosterone therapy risks:

  • Cardiovascular effects (though controversial)

  • Prostate health concerns

  • Sleep apnea exacerbation

  • Polycythemia (increased red blood cells)

  • Fertility effects

Growth hormone therapy risks:

  • Joint pain and swelling

  • Insulin resistance

  • Increased cancer risk concerns

  • Significantly higher cost

Proper medical supervision with regular monitoring is essential for anyone considering hormone replacement therapy.

The Future of Hormone Therapy for Sarcopenia

The research field is rapidly evolving. Current investigations are exploring:

  • Selective androgen receptor modulators (SARMs) that target muscle tissue specifically

  • Combination therapies addressing multiple hormonal pathways

  • Personalized medicine approaches based on individual hormone profiles

  • Novel biomarkers for predicting treatment response

  • Long-term safety and efficacy data

Key Takeaways

  1. Sarcopenia is a serious age-related condition affecting muscle mass, strength, and function, with hormonal decline playing a central role in its development.

  2. Testosterone levels decline with age and are strongly associated with muscle loss, making testosterone therapy a potentially valuable intervention for men with documented hypogonadism.

  3. Sex hormone-binding globulin (SHBG) affects hormone bioavailability, so measuring free hormone levels provides better assessment than total hormone levels alone.

  4. Multiple hormones beyond testosterone—including growth hormone, IGF-1, estrogen, and thyroid hormones—influence muscle health, suggesting that comprehensive hormonal assessment is important.

  5. Hormone supplementation consistently improves lean body mass in research studies, though effects on functional outcomes vary and are enhanced when combined with resistance exercise.

  6. Both the quantity and quality of muscle are affected by hormones, with effects on protein synthesis, satellite cell function, mitochondrial health, and inflammatory responses.

  7. Hormone therapy isn't appropriate for everyone—proper screening, diagnosis of hormone deficiency, and ongoing monitoring are essential for safe and effective treatment.

  8. The relationship between hormones and muscle is bidirectional—muscle loss can further disrupt hormonal balance, creating a cycle that hormone therapy may help break.

Frequently Asked Questions

Q: At what age should I start worrying about sarcopenia and hormone levels?

A: Muscle mass begins declining in your 30s, but the rate accelerates after 60. Consider baseline hormone testing in your 40s if you notice concerning symptoms like unexplained fatigue, difficulty building muscle, or declining strength. Early intervention is more effective than waiting until sarcopenia is advanced.

Q: Can I build muscle if I have low testosterone?

A: Yes, but it's more challenging. Resistance training stimulates muscle growth through multiple pathways, not just hormonal ones. However, addressing low testosterone can significantly enhance your results and overall quality of life.

Q: Is testosterone therapy safe for older men?

A: When properly prescribed and monitored, testosterone replacement therapy is generally safe for men with documented hypogonadism. However, it's not appropriate for everyone. Men with prostate cancer, severe sleep apnea, or certain cardiovascular conditions may not be good candidates. Comprehensive evaluation and ongoing monitoring are essential.

Q: Will increasing my testosterone make me gain muscle without exercise?

A: Testosterone supplementation can increase lean body mass even without exercise, but the gains are modest. The combination of hormone therapy and resistance training produces dramatically better results than either approach alone. Think of testosterone as creating a favorable environment for muscle growth, while exercise provides the stimulus.

Q: What's the difference between testosterone therapy and anabolic steroids?

A: Medical testosterone therapy aims to restore hormone levels to normal physiological ranges under medical supervision. Anabolic steroids typically involve supraphysiological doses (far above normal levels) without medical oversight, carrying significantly higher risks and often illegal.

Q: How long does it take to see results from hormone therapy?

A: Most men notice initial improvements in energy and mood within 2-4 weeks. Measurable increases in muscle mass typically appear within 3-6 months, with continued improvements over the first year. Strength gains may take longer and depend heavily on training.

Q: Can women benefit from testosterone therapy for muscle loss?

A: Some research suggests low-dose testosterone therapy may benefit postmenopausal women with sarcopenia, though this is less established than in men. Women naturally have much lower testosterone levels, so dosing is more delicate. Estrogen replacement therapy also plays important roles in women's muscle health.

Q: Are there natural ways to boost testosterone and prevent sarcopenia?

A: Yes! Resistance training, adequate sleep, stress management, maintaining healthy body weight, vitamin D sufficiency, and proper nutrition (especially adequate protein and zinc) all support healthy hormone levels. However, these strategies may not fully compensate for age-related decline.

Q: Does insurance cover hormone therapy for sarcopenia?

A: Coverage varies significantly. Many insurers cover testosterone replacement for documented hypogonadism but may not specifically cover treatment for sarcopenia alone. Growth hormone therapy is rarely covered for sarcopenia. Check with your insurance provider and healthcare team.

Q: What hormone levels indicate I might benefit from therapy?

A: For men, total testosterone below 300 ng/dL generally indicates hypogonadism, though symptoms matter more than numbers alone. Your doctor should also check free testosterone and SHBG for a complete picture. For women, hormone assessment is more complex and should be individualized based on symptoms and menopause status.

Take Action: Your Next Steps

Understanding the science behind hormone therapy and sarcopenia is the first step—but knowledge without action won't preserve your muscle mass and independence as you age.

Here's what you can do today:

  1. Get tested: If you're experiencing symptoms of muscle loss, fatigue, or declining strength, schedule comprehensive hormone testing with your healthcare provider. Request tests for total testosterone, free testosterone, SHBG, and other relevant hormones.

  2. Start resistance training: Regardless of your hormone status, progressive resistance exercise is the single most powerful intervention for preventing and treating sarcopenia. If you're new to strength training, consider working with a qualified trainer who understands training for older adults.

  3. Optimize your nutrition: Consume adequate protein (1.2-1.6 g/kg body weight daily), ensure sufficient vitamin D levels, and maintain overall nutritional quality to support muscle health and hormone production.

  4. Prioritize recovery: Quality sleep, stress management, and adequate rest between workouts all support healthy hormone levels and muscle recovery.

  5. Have an informed conversation: If testing reveals hormone deficiency, have a thorough discussion with your healthcare provider about whether hormone replacement therapy might be appropriate for you, weighing potential benefits against risks based on your individual health profile.

  6. Stay informed: The field of hormone therapy for sarcopenia is rapidly evolving. Follow reputable sources for updates on new research and treatment options.

Remember, sarcopenia isn't inevitable. While aging is unavoidable, the severe muscle loss and functional decline that many people experience can be prevented or significantly slowed. By understanding the hormonal factors at play and taking proactive steps—whether through lifestyle modifications, exercise, proper nutrition, or medical intervention when appropriate—you can maintain your strength, independence, and quality of life well into your later years.

Your muscles are worth fighting for. Start today.

This article is based on comprehensive scientific research and is intended for informational purposes. Always consult with healthcare professionals before making significant changes to your diet or exercise routine, especially if you have existing health conditions

Related Articles

Vitamin D Deficiency and Sarcopenia: The Critical Connection | DR T S DIDWAL

10 Warning Signs of Sarcopenia: How to Recognize Early Muscle Loss and Prevent Weakness | DR T S DIDWAL

How to Prevent Sarcopenia: Fight Age-Related Muscle Loss and Stay Strong | DR T S DIDWAL

Who Gets Sarcopenia? Key Risk Factors & High-Risk Groups Explained | DR T S DIDWAL

Sarcopenia: The Complete Guide to Age-Related Muscle Loss and How to Fight It | DR T S DIDWAL

Best Exercises for Sarcopenia: Strength Training Guide for Older Adults | DR T S DIDWAL

Best Supplements for Sarcopenia: Vitamin D, Creatine, and HMB Explained | DR T S DIDWAL

References

Basualto-Alarcón, C., Varela, D., Duran, J., Maass, R., & Estrada, M. (2014). Sarcopenia and androgens: A link between pathology and treatment. Frontiers in Endocrinology, 5, 217. https://doi.org/10.3389/fendo.2014.00217

Hosoi, T., Yakabe, M., Hashimoto, S., Akishita, M., & Ogawa, S. (2024). The roles of sex hormones in the pathophysiology of age-related sarcopenia and frailty. Reproductive Medicine and Biology, 23(1), e12569. https://doi.org/10.1002/rmb2.12569

Parahiba, S. M., Ribeiro, É. C. T., Corrêa, C., Bieger, P., Perry, I. S., & Souza, G. C. (2020). Effect of testosterone supplementation on sarcopenic components in middle-aged and elderly men: A systematic review and meta-analysis. Experimental Gerontology, 142, 111106. https://doi.org/10.1016/j.exger.2020.111106

Priego, T., Martín, A. I., González-Hedström, D., Granado, M., & López-Calderón, A. (2021). Role of hormones in sarcopenia. Vitamins and Hormones, 115, 535–570. https://doi.org/10.1016/bs.vh.2020.12.021

Qin, H., Jiao, W., & Liao, G. (2025). The association of low muscle mass with serum sex hormones and sex hormone-binding globulin. Journal of Cachexia, Sarcopenia and Muscle, 16(5), e70056. https://doi.org/10.1002/jcsm.70056

Shin, M. J., Jeon, Y. K., & Kim, I. J. (2018). Testosterone and sarcopenia. The World Journal of Men's Health, 36(3), 192–198. https://doi.org/10.5534/wjmh.180001